02/05/2024
6:53 PM | Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
| Form SC 13D/A | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/26/2024
4:26 PM | Navidea Biopharmaceuticals (Filer)
| Form POS AM | |
|
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form POS AM | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form POS AM | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form POS AM | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:28 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:28 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:28 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/16/2024
12:53 PM | Navidea Biopharmaceuticals (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
12/22/2023
6:54 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/21/2023
2:32 PM | Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
| Form SC 13D/A | |
12/05/2023
5:26 PM | Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
10:49 AM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
5:43 PM | Moss Dana J (Reporting)
Navidea Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
5:10 PM | Navidea Biopharmaceuticals (Issuer)
Stefanelli Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
3:55 PM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
1:58 PM | Navidea Biopharmaceuticals (Filer)
| Form DEFA14A | |
10/23/2023
12:56 PM | Navidea Biopharmaceuticals (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
10/05/2023
3:21 PM | Navidea Biopharmaceuticals (Filer)
| Form DEF 14A | |
09/15/2023
2:42 PM | Navidea Biopharmaceuticals (Filer)
| Form PRE 14A | |
09/10/2023
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
08/15/2023
4:53 PM | Dais Craig (Reporting)
Navidea Biopharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/11/2023
3:06 PM | Navidea Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2023
5:00 PM | Moss Dana J (Reporting)
Navidea Biopharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2023
5:02 PM | Moss Dana J (Reporting)
Navidea Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
3:39 PM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
4:30 PM | Navidea Biopharmaceuticals (Filer)
| Form DEF 14A | |
07/03/2023
3:01 PM | Bain Irwin Allen (Filed by)
Navidea Biopharmaceuticals (Subject)
| Form SC 13G/A | |
06/30/2023
9:46 AM | Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:22 PM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:24 PM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad) This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate…
And a cumulative gain of 1729%.
How does it all work? Click Here To Get Your Free Copy |
06/16/2023
4:26 PM | Navidea Biopharmaceuticals (Filer)
| Form PRE 14A | |
06/16/2023
3:20 PM | Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
| Form SC 13D/A | |
06/15/2023
5:35 PM | Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
10:03 AM | Navidea Biopharmaceuticals (Issuer)
Stefanelli Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
1:41 PM | Navidea Biopharmaceuticals (Issuer)
Stefanelli Jill (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/28/2023
9:55 AM | Navidea Biopharmaceuticals (Filer)
| Form 424B5 | |
04/28/2023
9:56 AM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
